RECENT FUNDING ROUNDS
| Company | Country | Profile | Funding round | Value | Date | |
|---|---|---|---|---|---|---|
|
StethoMe | Medically certified AI algorithms and device for automatic and remote lung and heart screening. | Series A | USD 2,500,000 | ||
|
Sword Health | Series A | USD 8,000,000 | |||
|
|
Sword Health | Seed | USD 4,600,000 | |||
|
Zilico Ltd | Electrical Impedance Spectroscopy (EIS) cancer diagnostic device technology. | Venture | USD 19,000,000 | ||
|
Cardiac Insight Inc | Developer of advanced body-worn digital health care information devices for cardiology, respiratory and other complex disease states. | Series C-1 | USD 4,500,000 | ||
|
Sinovision Technology (Beijing) Co Ltd | Developer of computed tomography (CT) scanners. | Venture | CNY 200,000,000 | ||
|
Auris Surgical Robotics Inc | Venture | USD 280,000,000 | |||
|
|
StethoMe | Medically certified AI algorithms and device for automatic and remote lung and heart screening. | Seed | PLN 6,500,000 | ||
|
|
StethoMe | Medically certified AI algorithms and device for automatic and remote lung and heart screening. | Seed | USD 2,000,000 | ||
|
Intrinsic Therapeutics Inc | Debt | USD 21,000,000 |
MOST ACTIVE INVESTORS
MOST ACTIVE ACQUIRERS
| Auris Surgical Robotics Inc | US | 1 |
BEST FUNDED
Electrical Impedance Spectroscopy (EIS) cancer diagnostic device technology.
Medically certified AI algorithms and device for automatic and remote lung and heart screening.
Developer of advanced body-worn digital health care information devices for cardiology, respiratory and other complex disease states.
Canadian medical device company and the world leader in fluorescence endoscopy for improved cancer detection.
![[current-page:title] logo](/sites/default/files/styles/thumbnail/public/default_images/_company.png?itok=PsC3hz2r)
High performance nucleic acid purification, enrichment, and sequence detection.
Developing the GridION system, a new generation of technology that uses nanopores - very small holes created in electrically resistant membranes.
Developer of a new patented diagnostic test system that will significantly improve identification and treatment of glaucoma
Developer of home haemodialysis systems, called “SelfCare”.